89 related articles for article (PubMed ID: 27516492)
1. Viral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive Filtration.
Roush D; Ma J
PDA J Pharm Sci Technol; 2016 Sep; 70(5):417-427. PubMed ID: 27516492
[No Abstract] [Full Text] [Related]
2. Proceedings of the 2019 Viral Clearance Symposium, Session 6: Virus-Retentive Filtration.
O'Donnell S; Bolton G
PDA J Pharm Sci Technol; 2022; 76(4):349-357. PubMed ID: 34911825
[TBL] [Abstract][Full Text] [Related]
3. Viral clearance using traditional, well-understood unit operations (session I): virus-retentive filtration.
Chen D
PDA J Pharm Sci Technol; 2014; 68(1):38-50. PubMed ID: 24504235
[No Abstract] [Full Text] [Related]
4. Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation.
Ma J; Roush D
PDA J Pharm Sci Technol; 2016 Sep; 70(5):410-416. PubMed ID: 27516488
[No Abstract] [Full Text] [Related]
5. A survey of quality attributes of virus spike preparations used in clearance studies.
Miesegaes G; Lute S; Dement-Brown J; Kaushal S; Strauss D; Chen D; Brorson K
PDA J Pharm Sci Technol; 2012; 66(5):420-33. PubMed ID: 23035026
[TBL] [Abstract][Full Text] [Related]
6. Viral clearance of traditional unit operations: virus-retentive filtration.
Chen Q; Chen D
PDA J Pharm Sci Technol; 2015; 69(1):142-53. PubMed ID: 25691722
[No Abstract] [Full Text] [Related]
7. Development of a transient inline spiking system for evaluating virus clearance in continuous bioprocessing-Proof of concept for virus filtration.
Malakian A; Jung SY; Afzal MA; Carbrello C; Giglia S; Johnson M; Miller C; Rayfield W; Boenitz D; Cetlin D; Zydney AL
Biotechnol Bioeng; 2022 Aug; 119(8):2134-2141. PubMed ID: 35470427
[TBL] [Abstract][Full Text] [Related]
8. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
[TBL] [Abstract][Full Text] [Related]
9. Analysis of viral clearance unit operations for monoclonal antibodies.
Miesegaes G; Lute S; Brorson K
Biotechnol Bioeng; 2010 Jun; 106(2):238-46. PubMed ID: 20073086
[TBL] [Abstract][Full Text] [Related]
10. Characterization of coliphage PR772 and evaluation of its use for virus filter performance testing.
Lute S; Aranha H; Tremblay D; Liang D; Ackermann HW; Chu B; Moineau S; Brorson K
Appl Environ Microbiol; 2004 Aug; 70(8):4864-71. PubMed ID: 15294825
[TBL] [Abstract][Full Text] [Related]
11. Achieving high mass-throughput of therapeutic proteins through parvovirus retentive filters.
Bolton GR; Basha J; Lacasse DP
Biotechnol Prog; 2010; 26(6):1671-7. PubMed ID: 20859931
[TBL] [Abstract][Full Text] [Related]
12. A three plus three parameters mechanistic model for viral filtration.
Misra P; Sinha A; Rathore AS; Shukla A; Mir FQ
Biotechnol Prog; 2017 Nov; 33(6):1538-1547. PubMed ID: 28699320
[TBL] [Abstract][Full Text] [Related]
13. Session 3.2: Viral Clearance of Emerging Unit Operations: Membrane Chromatography, Other Methods, Etc.
Gallo C
PDA J Pharm Sci Technol; 2016 Sep; 70(5):451-461. PubMed ID: 27516485
[No Abstract] [Full Text] [Related]
14. A novel approach to achieving modular retrovirus clearance for a parvovirus filter.
Stuckey J; Strauss D; Venkiteshwaran A; Gao J; Luo W; Quertinmont M; O'Donnell S; Chen D
Biotechnol Prog; 2014; 30(1):79-85. PubMed ID: 24123923
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic evaluation of virus clearance by depth filtration.
Venkiteshwaran A; Fogle J; Patnaik P; Kowle R; Chen D
Biotechnol Prog; 2015; 31(2):431-7. PubMed ID: 25683459
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic failure mode investigation and resolution of parvovirus retentive filters.
LaCasse D; Lute S; Fiadeiro M; Basha J; Stork M; Brorson K; Godavarti R; Gallo C
Biotechnol Prog; 2016 Jul; 32(4):959-70. PubMed ID: 27160325
[TBL] [Abstract][Full Text] [Related]
17. Viral clearance using traditional, well-understood unit operations: session 1.2. Anion exchange chromatography; and session 1.3. Protein a chromatography.
Roush D
PDA J Pharm Sci Technol; 2015; 69(1):154-62. PubMed ID: 25691723
[No Abstract] [Full Text] [Related]
18. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
[TBL] [Abstract][Full Text] [Related]
19. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
[TBL] [Abstract][Full Text] [Related]
20. Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation.
Chen Q
PDA J Pharm Sci Technol; 2014; 68(1):17-22. PubMed ID: 24504232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
